Infections, Rotavirus Clinical Trial
Official title:
Hospital-based Surveillance to Estimate the Disease Burden of Rotavirus Gastroenteritis in Children < 5 Years of Age in Romania
Verified date | April 2015 |
Source | GlaxoSmithKline |
Contact | n/a |
Is FDA regulated | No |
Health authority | Romania: Minister of Health |
Study type | Observational |
The purpose of this hospital based study is to estimate the proportion of rotavirus gastroenteritis in children < 5 years of age in Romania.
Status | Completed |
Enrollment | 1234 |
Est. completion date | January 2010 |
Est. primary completion date | January 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | N/A to 5 Years |
Eligibility |
Inclusion Criteria: - A male or female child aged < 5 years at the time of admission. A child becomes ineligible on the day of her/his fifth birthday. - A subject, who during the study period: - Is hospitalised for acute gastroenteritis Or - Visits an emergency room for acute gastroenteritis Or - Has rotavirus positive laboratory results and develops acute gastroenteritis at least 48 hours after hospitalisation Exclusion Criteria: |
Observational Model: Cohort, Time Perspective: Prospective
Country | Name | City | State |
---|---|---|---|
Romania | GSK Investigational Site | Bucharest | |
Romania | GSK Investigational Site | Bucharest | |
Romania | GSK Investigational Site | Cluj | |
Romania | GSK Investigational Site | Cluj Napoca | |
Romania | GSK Investigational Site | Constanta | |
Romania | GSK Investigational Site | Craiova | |
Romania | GSK Investigational Site | Sibiu | |
Romania | GSK Investigational Site | Timisoara |
Lead Sponsor | Collaborator |
---|---|
GlaxoSmithKline |
Romania,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Proportion of rotavirus gastroenteritis among all acute gastroenteritis hospitalisations of children < 5 years of age | At least 12 months from study start | No | |
Primary | Proportion of rotavirus gastroenteritis among all acute gastroenteritis emergency room visits for children < 5 years of age | At least 12 months from study start | No | |
Primary | Incidence of medical care associated rotavirus gastroenteritis among all hospitalised children < 5 years of age | At least 12 months from study start | No | |
Secondary | Age distribution of children with rotavirus gastroenteritis | At least 12 months from study start | No | |
Secondary | Percentage of rotavirus genotypes amongst all isolated strains in children < 5 years of age | At least 12 months from study start | No | |
Secondary | Potential risk factors for rotavirus gastroenteritis | At least 12 months from study start | No | |
Secondary | Rotavirus gastroenteritis associated costs | At least 12 months from study start | No | |
Secondary | Proportion of acute gastroenteritis among all hospitalisations of children < 5 years of age | At least 12 months from study start | No | |
Secondary | Proportion of community acquired acute gastroenteritis among all emergency room visits for children < 5 years of age | At least 12 months from study start | No | |
Secondary | Seasonal distribution (if appropriate) of rotavirus among all children < 5 years of age | At least 12 months from study start | No | |
Secondary | Severity of rotavirus among all children < 5 years of age | At least 12 months from study | No | |
Secondary | Proportion of rotavirus gastroenteritis among all hospitalisations of children < 5 years of age | At least 12 months from study start | No | |
Secondary | Proportion of community acquired rotavirus gastroenteritis among all emergency room visits for children < 5 years of age | At least 12 months from study start | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01435967 -
Observational Study on Rotavirus Gastroenteritis Epidemiology, Impact of Lyophilised vs. Liquid Formulation of Rotarix™
|
N/A | |
Completed |
NCT00345956 -
To Evaluate Immunogenicity, Reactogenicity & Safety of 2 Doses of GSK Bio HRV Liquid Vaccine Given to Infants (Vietnam)
|
Phase 3 | |
Completed |
NCT00370318 -
Prophylactic Antipyretic Treatment in Children Receiving Pneumococcal Conjugate and Standard Infant Vaccines
|
Phase 3 | |
Completed |
NCT00140686 -
To Test 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants in Co-administration With Specific Childhood Vaccines
|
Phase 3 | |
Completed |
NCT00383903 -
Evaluate Safety & Immunogenicity of 2 or 3 Doses of GSK HRV Vaccine in Healthy Infants in South Africa
|
Phase 2 | |
Completed |
NCT00750893 -
Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix (Human Rotavirus Vaccine) in Infants
|
||
Completed |
NCT00533507 -
Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 8 Weeks of Age
|
Phase 3 | |
Completed |
NCT00363545 -
To Assess Immunogenicity, Reactogenicity & Safety of 2 Formulations of GSK's HRV Vaccine as 2-dose Vaccination (Infants)
|
Phase 3 | |
Completed |
NCT02914184 -
Evaluation of Immunogenicity and Safety of Two Formulations of GSK Biologicals' Human Rotavirus (HRV) Vaccine (444563), in Healthy Infants Starting at Age 6-12 Weeks
|
Phase 3 | |
Completed |
NCT00489567 -
Hospital-based Surveillance to Collect Prospective Data to Estimate the Disease Burden of Severe RV GE in Sweden
|
N/A | |
Completed |
NCT01733862 -
Study to Assess the Impact of Vaccination on Hospitalizations and Outpatient Visits Due to Rotavirus Gastroenteritis
|
||
Completed |
NCT00779779 -
Evaluation of Reactogenicity and Safety of GSK Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Infants
|
||
Completed |
NCT00382772 -
A Study in Infants to Test Two Preparations (Freeze-dried or Liquid) of the Rotavirus Vaccine (HRV Vaccine).
|
Phase 3 | |
Completed |
NCT00729001 -
Study of Two Doses of GSK Biologicals' Live Attenuated HRV Vaccine (Two Different Formulations) in Healthy Infants.
|
Phase 2 | |
Completed |
NCT00353366 -
To Evaluate Safety & Reactogenicity of GSK Bio's Human Rotavirus (HRV) Vaccine in Filipino Infants at Least 6 Weeks of Age at First Vaccination
|
||
Completed |
NCT01198769 -
Immunogenicity and Safety Study of Rotarix TM in Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth.
|
Phase 4 | |
Completed |
NCT00385320 -
Evaluate Protective Efficacy of Diff Strengths of Human Rotavirus Vaccine After Admn of 2 Doses to Infants Aged 2 Months
|
Phase 2 | |
Completed |
NCT00432380 -
A Study to Evaluate Immune Response and Safety of Two Doses of GSK Biologicals' HRV Liquid Vaccine in Healthy Infants.
|
Phase 2 | |
Completed |
NCT01563159 -
Number of Rotavirus (RV) Related Hospitalizations in Belgium - Season 2010-2011
|
N/A | |
Completed |
NCT01339221 -
Epidemiological, Observational and Post Marketing Study of Rotarix™ in Children With Severe Gastroenteritis in Belgium
|
N/A |